Literature DB >> 30291411

Impact of a prolonged interatrial conduction time for predicting the recurrence of atrial fibrillation after circumferential pulmonary vein isolation of persistent atrial fibrillation.

Satoshi Higuchi1, Koichiro Ejima2, Morio Shoda1, Eri Yamamoto1, Yuji Iwanami1, Daigo Yagishita1, Nobuhisa Hagiwara1.   

Abstract

There are some cases that are difficult to cure with only circumferential pulmonary vein isolation (CPVI) of persistent atrial fibrillation (PerAF). Recently, prolonged interatrial conduction times (IACTs), which seem to be associated with progressive remodeled atria, have been reported as a predictor of new-onset AF. This study aimed to investigate the prognostic value of a prolonged IACT for predicting AF recurrences after CPVI of PerAF. One hundred thirteen patients who underwent CPVI without an empirical substrate modification of PerAF were retrospectively analyzed. The IACT was defined as the interval from the earliest P-wave onset on the ECG to the latest activation in the coronary sinus and was measured after achieving the CPVI and conversion to sinus rhythm. During a mean 22.7-month follow-up after the initial procedure, 56 patients (50%) had AF recurrences. Patients with AF recurrence had a longer IACT than those without AF recurrence (p < 0.001). The best discriminative cut-off value for the IACT was 123 ms (sensitivity 53%, specificity 85%). In a Cox multivariate analysis, a prolonged IACT of ≥ 123 ms was the only independent predictor (hazard ratio: 2.38; 95% confidence interval: 1.36-4.16, p = 0.002) of being associated with the incidence of an AF recurrence. Even after multiple CPVI procedures, patients with an IACT ≥ 123 ms had a higher AF recurrence rate than those with an IACT < 123 ms (p = 0.002). In conclusion, a prolonged IACT of ≥ 123 ms may be a useful marker for predicting AF recurrences after both initial and multiple CPVI procedures for PerAF.

Entities:  

Keywords:  Catheter ablation; Circumferential pulmonary vein isolation; Interatrial conduction time; Persistent atrial fibrillation; Predictor

Mesh:

Year:  2018        PMID: 30291411     DOI: 10.1007/s00380-018-1272-8

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  19 in total

1.  2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; Jose Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  Europace       Date:  2012-03-01       Impact factor: 5.214

2.  Impact of atrial remodeling on the outcome of radiofrequency catheter ablation of paroxysmal atrial fibrillation.

Authors:  Koichiro Ejima; Ken Kato; Kotaro Arai; Keiko Fukushima; Noritoshi Fukushima; Tsuyoshi Suzuki; Kentaro Yoshida; Toshiaki Nuki; Shoko Uematsu; Hiromi Hoshi; Tetsuyuki Manaka; Kyomi Ashihara; Morio Shoda; Nobuhisa Hagiwara
Journal:  Circ J       Date:  2014-02-21       Impact factor: 2.993

3.  Response to Letter Regarding Article, "Ablation of Persistent Atrial Fibrillation Targeting Low-Voltage Areas With Selective Activation Characteristics".

Authors:  Amir S Jadidi; Heiko Lehrmann; Cornelius Keyl; Jérémie Sorrel; Viktor Markstein; Jan Minners; Chan-Il Park; Arnaud Denis; Pierre Jais; Mélèze Hocini; Clemens Potocnik; Juergen Allgeier; Willibald Hochholzer; Claudia Herrera-Siklody; Steve Kim; Youssef El Omri; Franz-Josef Neumann; Reinhold Weber; Michel Haissaguerre; Thomas Arentz
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-07

4.  Influence of underlying substrate on atrial tachyarrhythmias after pulmonary vein isolation.

Authors:  Masaharu Masuda; Masashi Fujita; Osamu Iida; Shin Okamoto; Takayuki Ishihara; Kiyonori Nanto; Takashi Kanda; Tatsuya Shiraki; Akihiro Sunaga; Yasuhiro Matsuda; Masaaki Uematsu
Journal:  Heart Rhythm       Date:  2015-12-19       Impact factor: 6.343

5.  Associations between the atrial electromechanical interval, atrial remodelling and outcome of catheter ablation in paroxysmal atrial fibrillation.

Authors:  Tze-Fan Chao; Shih-Hsien Sung; Kang-Ling Wang; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Kazuyoshi Suenari; Cheng-Hung Li; Kuo-Chang Ueng; Tsu-Juey Wu; Shih-Ann Chen
Journal:  Heart       Date:  2010-12-13       Impact factor: 5.994

6.  Is It Necessary to Achieve a Complete Box Isolation in the Case of Frequent Esophageal Temperature Rises? Feasibility of Shifting to a Partial Box Isolation Strategy for Patients With Non-Paroxysmal Atrial Fibrillation.

Authors:  Satoshi Higuchi; Hiroshi Sohara; Yoshinori Nakamura; Minoru Ihara; Yoshio Yamaguchi; Morio Shoda; Nobuhisa Hagiwara; Shutaro Satake
Journal:  J Cardiovasc Electrophysiol       Date:  2016-06-14

7.  Left atrial volume calculated by multi-detector computed tomography may predict successful pulmonary vein isolation in catheter ablation of atrial fibrillation.

Authors:  João Abecasis; Raquel Dourado; António Ferreira; Carla Saraiva; Diogo Cavaco; Katya Reis Santos; Francisco Belo Morgado; Pedro Adragão; Aniceto Silva
Journal:  Europace       Date:  2009-07-23       Impact factor: 5.214

8.  A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate.

Authors:  Koonlawee Nademanee; John McKenzie; Erol Kosar; Mark Schwab; Buncha Sunsaneewitayakul; Thaveekiat Vasavakul; Chotikorn Khunnawat; Tachapong Ngarmukos
Journal:  J Am Coll Cardiol       Date:  2004-06-02       Impact factor: 24.094

9.  Value of P-wave signal averaging to predict atrial fibrillation recurrences after pulmonary vein isolation.

Authors:  Coralie Blanche; Nam Tran; Fabio Rigamonti; Haran Burri; Marc Zimmermann
Journal:  Europace       Date:  2012-08-31       Impact factor: 5.214

10.  Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint.

Authors:  Daniel Scherr; Paul Khairy; Shinsuke Miyazaki; Valerie Aurillac-Lavignolle; Patrizio Pascale; Stephen B Wilton; Khaled Ramoul; Yuki Komatsu; Laurent Roten; Amir Jadidi; Nick Linton; Michala Pedersen; Matthew Daly; Mark O'Neill; Sebastien Knecht; Rukshen Weerasooriya; Thomas Rostock; Martin Manninger; Hubert Cochet; Ashok J Shah; Sunthareth Yeim; Arnaud Denis; Nicolas Derval; Meleze Hocini; Frederic Sacher; Michel Haissaguerre; Pierre Jais
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-12-20
View more
  3 in total

1.  Prolonged P-wave duration in sinus rhythm pre-ablation is associated with atrial fibrillation recurrence after pulmonary vein isolation-A systematic review and meta-analysis.

Authors:  Raymond Pranata; Emir Yonas; Rachel Vania
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-04-14       Impact factor: 1.468

Review 2.  Use of P wave indices to evaluate efficacy of catheter ablation and atrial fibrillation recurrence: a systematic review and meta-analysis.

Authors:  Peng Liu; Tingting Lv; Ying Yang; Qinggele Gao; Ping Zhang
Journal:  J Interv Card Electrophysiol       Date:  2022-04-30       Impact factor: 1.900

3.  Value of dual Doppler echocardiography for prediction of atrial fibrillation recurrence after radiofrequency catheter ablation.

Authors:  Fengjiao Chen; Qinliang Sun; Hairu Li; Shaohui Qu; Weidong Yu; Shuangquan Jiang; Jiawei Tian
Journal:  BMC Cardiovasc Disord       Date:  2019-11-15       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.